ACCESSION: MSBNK-SMB_Measured-HSA032P0229009
RECORD_TITLE: Characterized; Leucylproline; LC-ESI-QTOF; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.25, Processed 2025.02.25, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 15.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 60
COMMENT: NUM_AVERAGED_SPEC 12
COMMENT: RAW_SPEC {'RA10-pos_1654': {'bp': 13512.0, 'sum': 21697.0}, 'RA17-pos_1598': {'bp': 11169.0, 'sum': 22324.0}, 'QC4-pos_1577': {'bp': 8531.0, 'sum': 15118.0}, 'HC16-pos_1854': {'bp': 7017.0, 'sum': 14059.0}, 'HC22-pos_1508': {'bp': 6834.0, 'sum': 16881.0}, 'RA16-pos_1462': {'bp': 6431.0, 'sum': 12542.0}, 'HC7-pos_1551': {'bp': 4496.0, 'sum': 8222.0}, 'HC21-pos_1480': {'bp': 3208.0, 'sum': 7431.0}, 'RA9-pos_1494': {'bp': 3201.0, 'sum': 5230.0}, 'RA15-pos_1732': {'bp': 2873.0, 'sum': 5036.0}, 'HC18-pos_1574': {'bp': 2675.0, 'sum': 6285.0}, 'RA9-pos_1454': {'bp': 1382.0, 'sum': 4203.0}}
COMMENT: RETENTION_TIME_STDEV 0.020
COMMENT: PRECURSOR_M/Z_RAW 229.153834
COMMENT: PRECURSOR_M/Z_STDEV 0.000644
COMMENT: PRECURSOR_IN_MS1 mz 229.154397; int 390.736; delta(ppm) 10.638604
COMMENT: PROPOSED_CHARGE_STATE +1; mz 230.157196; int 43.535; cor 0.783
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 14.710; C10H21N4P; [M+H]+; delta(ppm) -14.709813
COMMENT: PROPOSED_MF SevenGoldenRules 8.845; C9H25O4P; [M+H]+; delta(ppm) -8.845173
COMMENT: PROPOSED_MF SevenGoldenRules 1.609; C11H20N2O3; [M+H]+; delta(ppm) -1.608612
COMMENT: PROPOSED_MF MS-FINDER 4.800; C11H20N2O3; [M+H]+; delta(ppm) -1.601323
COMMENT: PROPOSED_MF MS-FINDER 3.195; C7H16N8O; [M+H]+; delta(ppm) 10.117200
COMMENT: PROPOSED_MF MS-FINDER 2.715; C7H24N4S2; [M+H]+; delta(ppm) 12.161268
COMMENT: PROPOSED_MF SIRIUS5_Sirius 23.551; C11H20N2O3; [M+H]+; delta(ppm) -1.601323
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C11H20N2O3; [M+H]+; delta(ppm) -1.601323
COMMENT: PROPOSED_MF SIRIUS6_Sirius 33.330; C11H20N2O3; [M+H]+; delta(ppm) -1.601323
COMMENT: PROPOSED_MF SIRIUS6_Sirius 22.301; C9H18N5O2; [M+H]+; delta(ppm) 4.257904
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.416; C10H24N2Si2; [M+H]+; delta(ppm) -218168.170190
COMMENT: PROPOSED_MF SIRIUS6_Sirius -6.512; C2H18N11S; [M+H]+; delta(ppm) 1.265143
COMMENT: PROPOSED_MF SIRIUS6_Sirius -7.871; C3H19N9OP; [M+H]+; delta(ppm) 8.768288
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C11H20N2O3; [M+H]+; delta(ppm) -1.601323
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 2.000; ZKQOUHVVXABNDG-IUCAKERBSA-N; C11H20N2O3; Spectral Match to Pro-Leu from NIST14
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 2.000; OCYROESYHWUPBP-CIUDSAMLSA-N; C11H20N2O3; Spectral Match to Pro-Ile from NIST14
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.556; QEDMGXHHRXIZDW-MDWBIBFBNA-N; [M+H]+; CC(C)C[C@H](N)C(=O)OC(=O)[C@@H]1CCCN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.335; VTJUNIYRYIAIHF-UHFFFAOYNA-N; [M+H]+; CC(C)CC(N)C(=O)N1CCCC1C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.200; BBIXOODYWPFNDT-UHFFFAOYNA-N; [M+H]+; CCC(C)C(N)C(=O)N1CCCC1C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.726; ZKQOUHVVXABNDG-IUCAKERBSA-N; [M+H]+; CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.711; SJHBIBWCKVQUAW-UHFFFAOYSA-N; [M+H]+; O=C(NCC1OCC(NC2CCC2)C1O)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.429; VTJUNIYRYIAIHF-UHFFFAOYNA-N; [M+H]+; Leucylproline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.209; BBIXOODYWPFNDT-UHFFFAOYNA-N; [M+H]+; Isoleucylproline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.006; QEDMGXHHRXIZDW-MDWBIBFBNA-N; [M+H]+; UNPD164887
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.932; ZKQOUHVVXABNDG-IUCAKERBSA-N; [M+H]+; Pro-Leu
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.912; OCYROESYHWUPBP-CIUDSAMLSA-N; [M+H]+; Pro-Ile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.806; ZDLIFNAOCJUWIZ-UHFFFAOYSA-N; [M+H]+; 1-[5-(morpholine-4-carbonyl)oxolan-2-yl]ethan-1-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.790; SJHBIBWCKVQUAW-UHFFFAOYSA-N; [M+H]+; N-{[4-(cyclobutylamino)-3-hydroxyoxolan-2-yl]methyl}acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.770; RXIAXFORFJTOBA-UHFFFAOYSA-N; [M+H]+; N-({4-[(cyclopropylmethyl)amino]-3-hydroxyoxolan-2-yl}methyl)acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.733; LSGIJENCKWZHBZ-UHFFFAOYSA-N; [M+H]+; 2-amino-4-(piperidin-1-yl)-6,8-dioxabicyclo[3.2.1]octan-3-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.732; OHFWNCJCJVITLU-UHFFFAOYSA-N; [M+H]+; N-{[4-(dimethylamino)-3-hydroxyoxolan-2-yl]methyl}cyclopropanecarboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.719; PWIAWDVLQXARBI-UHFFFAOYSA-N; [M+H]+; CNP0441908
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.627; KIFYKONQFFJILQ-SVGMAFHSNA-N; [M+H]+; UNPD22085
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.556; WSVFRGGLURJIMG-UHFFFAOYSA-N; [M+H]+; 4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.468; ZBPZAHHJROEFGA-LCYFTJDESA-N; [M+H]+; Oximoaspergillimide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.437; DSLSWBIYQALLJM-DSYSRCFZNA-N; [M+H]+; UNPD61830
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.255; VFHYOHZGJXDMKX-BRJQIKQINA-N; [M+H]+; UNPD120113
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; QEDMGXHHRXIZDW-MDWBIBFBNA-N; [M+H]+; UNPD164887
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.929; VTJUNIYRYIAIHF-UHFFFAOYNA-N; [M+H]+; Leucylproline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.926; BBIXOODYWPFNDT-UHFFFAOYNA-N; [M+H]+; Isoleucylproline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.851; RXIAXFORFJTOBA-UHFFFAOYSA-N; [M+H]+; N-({4-[(cyclopropylmethyl)amino]-3-hydroxyoxolan-2-yl}methyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.851; SJHBIBWCKVQUAW-UHFFFAOYSA-N; [M+H]+; N-{[4-(cyclobutylamino)-3-hydroxyoxolan-2-yl]methyl}acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.822; ZDLIFNAOCJUWIZ-UHFFFAOYSA-N; [M+H]+; 1-[5-(morpholine-4-carbonyl)oxolan-2-yl]ethan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.779; OCYROESYHWUPBP-CIUDSAMLSA-N; [M+H]+; Pro-Ile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.779; ZKQOUHVVXABNDG-IUCAKERBSA-N; [M+H]+; Pro-Leu
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.728; KIFYKONQFFJILQ-SVGMAFHSNA-N; [M+H]+; UNPD22085
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.725; OHFWNCJCJVITLU-UHFFFAOYSA-N; [M+H]+; N-{[4-(dimethylamino)-3-hydroxyoxolan-2-yl]methyl}cyclopropanecarboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.715; LSGIJENCKWZHBZ-UHFFFAOYSA-N; [M+H]+; 2-amino-4-(piperidin-1-yl)-6,8-dioxabicyclo[3.2.1]octan-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.680; PWIAWDVLQXARBI-UHFFFAOYSA-N; [M+H]+; CNP0441908
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.656; WSVFRGGLURJIMG-UHFFFAOYSA-N; [M+H]+; 4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.448; ZBPZAHHJROEFGA-LCYFTJDESA-N; [M+H]+; Oximoaspergillimide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.383; DSLSWBIYQALLJM-DSYSRCFZNA-N; [M+H]+; UNPD61830
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.383; VFHYOHZGJXDMKX-BRJQIKQINA-N; [M+H]+; UNPD120113
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.968; VTJUNIYRYIAIHF-IUCAKERBSA-N; [M+H]+; (2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.759; BBIXOODYWPFNDT-CIUDSAMLSA-N; [M+H]+; (2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.500; KLGLSIFVRXUXOR-UHFFFAOYSA-N; [M+H]+; methyl 3-[methyl-(1-methylpyrrolidine-2-carbonyl)amino]propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.437; YHFUWPUJUMZXBD-UHFFFAOYSA-N; [M+H]+; tert-butyl 4-carbamoylpiperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.398; ZJTVLGOMPFBUJI-UHFFFAOYSA-N; [M+H]+; piperidin-2-ylmethyl morpholine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.356; AQKNKAUJTJFUMG-UHFFFAOYSA-N; [M+H]+; tert-butyl N-(2-oxoazepan-3-yl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.266; ZFJVILVJFAFROD-UHFFFAOYSA-N; [M+H]+; tert-butyl N-(5-oxa-2-azaspiro[3.4]octan-7-yl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.256; APFUDGDIIFSTSD-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-carbamoylpiperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.248; QXGRPROTYZUJIO-UHFFFAOYSA-N; [M+H]+; tert-butyl 3,3-dimethyl-5-oxopiperazine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.239; ADXBXIQTAQOYRW-UHFFFAOYSA-N; [M+H]+; tert-butyl 2,2-dimethyl-3-oxopiperazine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.236; RLHNKFYDRHHRGW-UHFFFAOYSA-N; [M+H]+; tert-butyl 2,2-dimethyl-5-oxopiperazine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.235; WSVFRGGLURJIMG-UHFFFAOYSA-N; [M+H]+; 4-(cyclohexylcarbamoylamino)butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.216; OWPCUCUCFLFXJP-UHFFFAOYSA-N; [M+H]+; tert-butyl N-[(4-amino-2-oxabicyclo[2.1.1]hexan-1-yl)methyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.212; RGKSBCATNWZZSA-UHFFFAOYSA-N; [M+H]+; tert-butyl N-(2,3,3a,4,6,6a-hexahydro-1H-furo[3,4-b]pyrrol-3-yl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.209; VBEPRGVZKBMFPM-UHFFFAOYSA-N; [M+H]+; tert-butyl 7-hydroxy-2,5-diazaspiro[3.4]octane-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.192; YUSLKABKYBSTRL-UHFFFAOYSA-N; [M+H]+; tert-butyl 2-oxa-5,8-diazaspiro[3.5]nonane-8-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.188; AGXKOYRLTABGHX-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-(oxetan-3-ylamino)azetidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.184; BUGPWUMFGURMOU-UHFFFAOYSA-N; [M+H]+; ethyl 1-[2-(methylamino)acetyl]piperidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.152; SLFZPSKIMUPQSR-VIFPVBQESA-N; [M+H]+; tert-butyl (3S)-3-acetamidopyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.142; HDVGQNDLJKJMJF-UHFFFAOYSA-N; [M+H]+; tert-butyl 5-oxa-2,8-diazaspiro[3.5]nonane-8-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.142; YLMNCYATSGIUDS-DTWKUNHWSA-N; [M+H]+; tert-butyl (4aS,7aR)-3,4a,5,6,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.141; PJOOKTHHBXLUEC-UHFFFAOYSA-N; [M+H]+; tert-butyl 8-oxa-2,5-diazaspiro[3.5]nonane-5-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.093; AUXXIKSVHUSTOA-UHFFFAOYSA-N; [M+H]+; tert-butyl 3,4,4a,5,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazine-6-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.092; CTZAPXNYWJHZHJ-BDAKNGLRSA-N; [M+H]+; tert-butyl (4aR,7aS)-2,3,4a,5,7,7a-hexahydro-1H-furo[3,4-b]pyrazine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.088; NROFQLXUAGEBRC-UHFFFAOYSA-N; [M+H]+; tert-butyl 1-(aminomethyl)-2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.086; MYPAWHOIUKGJIE-UHFFFAOYSA-N; [M+H]+; tert-butyl 5-oxa-2,8-diazaspiro[3.5]nonane-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.085; FFWXQOJNRSOCRP-UHFFFAOYSA-N; [M+H]+; tert-butyl 8-oxa-2,5-diazaspiro[3.5]nonane-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.081; DJQMEIQMZYMIIH-UHFFFAOYSA-N; [M+H]+; tert-butyl 7-amino-5-oxa-2-azaspiro[3.4]octane-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.077; FMXFDLFANLZRLL-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-(3-hydroxyazetidin-3-yl)azetidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.055; ZJOPUBAGSPCYMR-UHFFFAOYSA-N; [M+H]+; 1-(propan-2-ylcarbamoylamino)cyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.899; DSLSWBIYQALLJM-ASODMVGOSA-N; [M+H]+; 2-methyl-6-[(4S,5R)-5-methyl-2-oxoimidazolidin-4-yl]hexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.861; WNVJAHZTVFGIDW-UHFFFAOYSA-N; [M+H]+; tert-butyl 7-amino-2-oxa-5-azaspiro[3.4]octane-5-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.861; GJENNCKWCAALDH-UHFFFAOYSA-N; [M+H]+; tert-butyl 5-oxa-2,9-diazaspiro[3.5]nonane-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.860; LSACGXFQGVBFLY-UHFFFAOYSA-N; [M+H]+; tert-butyl 8-amino-5-oxa-2-azaspiro[3.4]octane-2-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -8.836; VTJUNIYRYIAIHF; [M+H]+; Leucylproline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -18.827; BBIXOODYWPFNDT; [M+H]+; Isoleucylproline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -122.427; ZKQOUHVVXABNDG; [M+H]+; L-prolyl-L-leucine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -163.004; OCYROESYHWUPBP; [M+H]+; Prolylisoleucine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -235.896; QEDMGXHHRXIZDW; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -333.512; WSVFRGGLURJIMG; [M+H]+; 4-(3-cyclohexylureido)butanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -345.486; RXIAXFORFJTOBA; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -347.784; SLFZPSKIMUPQSR; [M+H]+; ACMC-20apkh
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -357.627; DSLSWBIYQALLJM; [M+H]+; .alpha.-Dethiobiotin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -360.861; BLWBKGMLORNBPP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -363.289; SNAWIFGTVBOMDL; [M+H]+; 4-[3-(diethylamino)propylamino]-4-oxobut-2-enoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -372.340; SJHBIBWCKVQUAW; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -388.115; ZBPZAHHJROEFGA; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -389.273; ZDLIFNAOCJUWIZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -394.449; YHFUWPUJUMZXBD; [M+H]+; Oprea1_340979
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -399.518; VFHYOHZGJXDMKX; [M+H]+; Desthiobiotin methyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -413.344; KIFYKONQFFJILQ; [M+H]+; (s)-1-n-boc-pipecolamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -416.872; AQKNKAUJTJFUMG; [M+H]+; n-2-boc-aminocaprolactam
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -430.739; YKUSCXGLCUEWME; [M+H]+; 2-[dimethyl-[3-(2-methylprop-2-enoylamino)propyl]azaniumyl]acetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -437.264; SEOPHOKLLMIZRR; [M+H]+; [[4-methyl-4-(prop-2-enoylamino)pentan-2-yl]amino] acetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -444.995; MYPAWHOIUKGJIE; [M+H]+; tert-butyl 5-oxa-2,8-diazaspiro[3.5]nonane-2-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -457.653; OHFWNCJCJVITLU; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -474.022; DJQMEIQMZYMIIH; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -479.994; LSACGXFQGVBFLY; [M+H]+; tert-butyl 8-amino-5-oxa-2-azaspiro[3.4]octane-2-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -514.479; YOGFCZDXOYHHJN; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -549.378; LSGIJENCKWZHBZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.549; VTJUNIYRYIAIHF; [M+H]+; Leucylproline
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -154.124; VTJUNIYRYIAIHF; [M+H]+; 1-(2-amino-4-methylpentanoyl)pyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -178.958; BBIXOODYWPFNDT; [M+H]+; 1-(2-amino-3-methylpentanoyl)pyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -303.265; ZKQOUHVVXABNDG; [M+H]+; 4-methyl-2-[(pyrrolidin-2-yl)formamido]pentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -326.990; OCYROESYHWUPBP; [M+H]+; 3-methyl-2-[(pyrrolidin-2-yl)formamido]pentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -362.789; KXONJPJIFNGMCN; [M+H]+; [1-[(2S)-2-carboxypyrrolidin-1-yl]-1-oxopropan-2-yl]-trimethylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -369.713; QEDMGXHHRXIZDW; [M+H]+; 2-amino-4-methylpentanoyl pyrrolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -387.093; WSVFRGGLURJIMG; [M+H]+; 4-{[(Cyclohexylamino)carbonyl]amino}butanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -412.889; ZBPZAHHJROEFGA; [M+H]+; Oximoaspergillimide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -416.122; SEOPHOKLLMIZRR; [M+H]+; [[4-Methyl-4-(prop-2-enoylamino)pentan-2-yl]amino] acetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -426.407; SLFZPSKIMUPQSR; [M+H]+; (R)-(+)-1-Boc-3-acetamidopyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.961; VTJUNIYRYIAIHF; [M+H]+; 1-(2-amino-4-methylpentanoyl)pyrrolidine-2-carboxylic acid
COMMENT: CONFIDENCE Level 3: Tentative candidate, Leucylproline, VTJUNIYRYIAIHF-IUCAKERBSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0011175;
CH$NAME: Leucylproline
CH$NAME: (2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidine-2-carboxylic acid
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C11H20N2O3
CH$EXACT_MASS: 228.147392
CH$SMILES: CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N
CH$IUPAC: InChI=1S/C11H20N2O3/c1-7(2)6-8(12)10(14)13-5-3-4-9(13)11(15)16/h7-9H,3-6,12H2,1-2H3,(H,15,16)/t8-,9-/m0/s1
CH$LINK: INCHIKEY VTJUNIYRYIAIHF-IUCAKERBSA-N
CH$LINK: PUBCHEM CID:80817
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 5.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 15.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 Âµm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min,` 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 2.464
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 229.154302
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00di-9100000000-6007c17f2f88a1d3b3e6
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  30.0342255 17.5339 30.034523 20.7763 11.94 0.5590 9 f{C1H4N1}/13.32ppm,p-C10H17N1O3
  44.0492952 33.0203 44.049603 17.8663 15.47 0.8309 10 f{C2H6N1}/-4.10ppm,p-C9H15N1O3
  69.0706867 31.8578 69.070833 8.5709 24.64 0.4752 10 f{C5H9}/11.73ppm,p-C6H12N2O3
  69.8520908 19.9699 69.852240 24.1224 13.19 0.1560 9 ?
  70.0649233 999.0000 70.065073 8.0497 0.00 1.0000 12 f{C4H8N1}/-2.89ppm,p-C7H13N1O3
  86.0962752 258.7467 86.096491 10.8832 67.36 0.9231 12 f{C5H12N1}/-1.75ppm,p-C6H9N1O3
  116.0707704 272.3577 116.071140 14.5256 76.67 0.7692 12 f{C5H10N1O2}/1.43ppm,p-C6H11N1O1
  120.0806697 28.6442 120.081063 16.1225 54.69 -0.1557 10 f{C8H10N1}/-0.88ppm,p-C3H11N1O3
PK$NUM_PEAK: 8
PK$PEAK: m/z int. rel.int.
  30.034225 17.53 17
  44.049295 33.02 33
  69.070687 31.86 31
  69.852091 19.97 19
  70.064923 999.00 999
  86.096275 258.75 258
  116.070770 272.36 272
  120.080670 28.64 28
//
